Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 2.10B NGN in the quarter ending September 30, 2025, with 46.06% growth. This brings the company's revenue in the last twelve months to 6.40B, up 68.75% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.

• Revenue (ttm): 6.40B
• Revenue Growth: +68.75%
• P/S Ratio: 8.95
• Revenue / Employee: 36.57M
• Employees: 175
• Market Cap: 57.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.49B	2.28B	102.98%
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%
Sep 30, 2021	3.05B	207.54M	7.31%